Chemours Files 8-K Report

Ticker: CC · Form: 8-K · Filed: 2024-11-13T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, corporate-event

Related Tickers: CC

TL;DR

Chemours filed an 8-K on 11/13/24 for an 'Other Event' - details TBD.

AI Summary

On November 13, 2024, The Chemours Company filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or significant operational updates but serves as a notification to the SEC regarding an event that may be of interest to investors. The report was filed from Wilmington, Delaware.

Why It Matters

This filing indicates a material event has occurred for Chemours, requiring disclosure to the SEC and investors, though the specific nature of the event is not detailed in the provided text.

Risk Assessment

Risk Level: low — The filing itself is a routine disclosure and does not inherently present new risks, but the 'Other Event' it refers to could carry risks depending on its nature.

Key Players & Entities

FAQ

What specific event prompted The Chemours Company to file this 8-K report on November 13, 2024?

The provided text states the filing is for an 'Other Event' but does not specify the nature of this event.

What is the primary purpose of an 8-K filing for a company like Chemours?

An 8-K filing is a Current Report required by the SEC to announce major corporate events that shareholders should be aware of, such as acquisitions, bankruptcy, or changes in management.

Where are The Chemours Company's principal executive offices located?

The Chemours Company's principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?

This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Does this filing provide any financial details or performance metrics for Chemours?

No, the provided text of the 8-K filing does not contain specific financial figures or performance metrics; it only indicates the filing of an 'Other Event'.

From the Filing

0000950170-24-126406.txt : 20241113 0000950170-24-126406.hdr.sgml : 20241113 20241113163324 ACCESSION NUMBER: 0000950170-24-126406 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241113 ITEM INFORMATION: Other Events FILED AS OF DATE: 20241113 DATE AS OF CHANGE: 20241113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 241454973 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20241113.htm 8-K 8-K 0001627223 false 0001627223 2024-11-13 2024-11-13     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   November 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐         Item 8.01 Other Events.   On November 13, 2024, The Chemours Company issued press releases announcing the launch and pricing of its offering of $600,000,000 aggregate principal amount of 8.000% senior unsecured notes due 2033 in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended. A copy of the foregoing press releases are attached hereto as Exhibits 99.1 and 99.2 and are incorporated into this Item 8.01 by reference.   Item 9.01 Financial Statements and Exhibits.   (d) Exhibits Exhibit 99.1 Launch Press Release, dated as of November 13, issued by The Chemours Company. Exhibit 99.2 Pricing Press Release, dated as of November 13, issued by The Chemours Company 104 Cover Page Interactive Data File (formatted as Inline X

View on Read The Filing